Solvent-free β-glucan-coated VD3 nanoliposomes: Physicochemical characterization and preliminary in vitro evaluation
Journal of Pharmacy & Pharmacognosy Research · 01.07.2026 · 14 (4) · 2654
DOI: 10.56499/jppres_14.4.2654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.07.2026. Verfasst von Jauharotus Shobahah und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Context
Vitamin D3 (VD3) has attracted interest in colorectal cancer research. Nevertheless, its limited solubility in aqueous media and low oral bioavailability restrict its pharmaceutical application. Solvent-free nanocarrier systems offer an alternative formulation approach that does not involve the use of organic solvents.
Aims
To develop β-glucan-coated VD3-loaded nanoliposomes and evaluate their physicochemical properties, storage stability, in vitro release, and preliminary effects on HCT-116 cell viability using the MTT assay.
Methods
VD3-loaded nanoliposomes were prepared using mild heating, probe sonication, virgin coconut oil (VCO) pre-dispersion, and β-glucan coating. The selected formulations were characterized using FTIR, dynamic light scattering, zeta potential, encapsulation efficiency, validated UV–Vis spectrophotometry, cryo-electron microscopy (Cryo-EM), in vitro drug release, storage stability, and MTT assays.
Results
The β-glucan-coated formulation exhibited a particle size of 201.8 ± 15.8 nm, PDI of 0.14 ± 0.09, zeta potential of −58.76 ± 1.86 mV, and encapsulation efficiency of 88.73 ± 0.70%, with a more uniform vesicular morphology than that of the uncoated formulation. It also showed a more controlled in vitro release profile and greater reduction in HCT-116 cell viability at intermediate concentrations. Conclusions: β-Glucan coating improved the physicochemical performance of VD3-loaded nanoliposomes, providing a more controlled in vitro release profile. The formulation also demonstrated a greater reduction in HCT-116 cell viability in a preliminary MTT assay, supporting further investigation under biorelevant oral delivery conditions. Further biological and preclinical studies are warranted to establish its performance under biorelevant and in vivo conditions.
Zitieren
APA
Shobahah, J., Winarni, D., Aly, M. A. N., Nur, N., Darmanto, W., Hudiyanti, D., Aun, L. I. L., & Wahyuningsih, S. P. A. (2026). Solvent-free β-glucan-coated VD3 nanoliposomes: Physicochemical characterization and preliminary in vitro evaluation. Journal of Pharmacy & Pharmacognosy Research, 14(4), 2654. https://doi.org/10.56499/jppres_14.4.2654
Vancouver
Shobahah J, Winarni D, Aly MAN, Nur N, Darmanto W, Hudiyanti D, et al. Solvent-free β-glucan-coated VD3 nanoliposomes: Physicochemical characterization and preliminary in vitro evaluation. Journal of Pharmacy & Pharmacognosy Research. 2026;14(4):2654. doi:10.56499/jppres_14.4.2654
BibTeX
@article{Shobahah2026,
author = {Shobahah, Jauharotus and Winarni, Dwi and Aly, M. Ainun Najib and Nur, Naswandi and Darmanto, Win and Hudiyanti, Dwi and Aun, Lionel In Lian and Wahyuningsih, Sri Puji Astuti},
title = {Solvent-free β-glucan-coated VD3 nanoliposomes: Physicochemical characterization and preliminary in vitro evaluation},
journal = {Journal of Pharmacy & Pharmacognosy Research},
year = {2026},
volume = {14},
number = {4},
pages = {2654},
doi = {10.56499/jppres_14.4.2654}
}
EUVIMED